Amphastar Pharmaceuticals Depreciation & Amortization 2011-2026 | AMPH

Annual Depreciation & Amortization Amphastar Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.6 M	28.2 M	25.7 M	12.6 M	10.2 M	9.03 M	7.06 M	6.05 M	6.42 M	12.2 M	11.3 M	12.5 M	11.2 M	9.66 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
31.6 M	6.05 M	13.8 M

Quarterly Depreciation & Amortization Amphastar Pharmaceuticals

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.08 M	14.1 M	14.6 M	7.37 M	-	13.4 M	13.1 M	6.82 M	-	9.62 M	3.06 M	3.4 M	-	3.42 M	3 M	2.74 M	-	2.5 M	2.64 M	2.48 M	-	2.46 M	2.03 M	2.05 M	-	1.7 M	1.66 M	1.64 M	-	10.4 M	6.51 M	3.06 M	-	9.67 M	6.24 M	3.1 M	-	9.01 M	6 M	2.95 M	-	8.52 M	5.63 M	2.77 M	-	9.24 M	6.04 M	2.94 M	-	8.19 M	5.4 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.6 M	1.64 M	5.84 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 7.14	1.56 %	$ 196 M	Israel
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Compugen Ltd. CGEN	475 K	$ 2.71	-3.16 %	$ 253 M	Israel
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Coherus BioSciences CHRS	1.3 M	$ 1.68	4.04 %	$ 197 M	USA
Anika Therapeutics ANIK	5.37 M	$ 14.64	-1.61 %	$ 210 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.46	1.74 %	$ 5.7 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 21.02	0.77 %	$ 2.67 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA